No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
This Is What Whales Are Betting On Amgen
Shareholders Should Be Pleased With Amgen Inc.'s (NASDAQ:AMGN) Price
Unusual Options Activity: NVDA, BIDU and Others Attract Market Bets, NVDA V/OI Ratio Reaches 3000.0
EST Jan 24th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Janux Therapeutics Promotes Zachariah McIver to Chief Medical Officer
Amgen Analyst Ratings
RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $324